News

Three Duke Surgery Faculty Members Receive Distinguished Professorships

Three faculty members from the Duke Department of Surgery have received distinguished professorships from Duke University. Distinguished professorships are awarded to the most distinguished faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.

Should Patients with Stage 2 Melanoma Undergo PET-CT Staging?


Studies fail to show early benefit, but changing landscape may increase utility of cross-sectional imaging
 

PET-CT for the initial staging of patients with stage 2 melanoma rarely showed evidence of distant metastatic disease, according to results presented in a poster session on October 11, 2018, at the American Society for Dermatologic Surgery annual meeting in Phoenix, AZ.

Duke Surgery Ranks First Nationwide in NIH Funding

The Blue Ridge Institute for Medical Research has released its 2018 rankings of NIH funding for basic and clinical science departments, revealing that Duke Surgery ranks highest nationwide with more than $30 million in funding committed to research.

Dr. Rosenberger to Present at SSO Annual Cancer Symposium

Please join the department in congratulating Laura Horst Rosenberger, MD, Assistant Professor of Surgery in the Division of Surgical Oncology, whose abstract has been accepted by the Society of Surgical Oncology (SSO) for presentation at the 72nd Annual Cancer Symposium.

Dr. Rosenberger will present her abstract, “Axillary Lymph Node Dissection in Node-Positive Breast Cancer: Are 10-Nodes Adequate and When is Enough, Enough?” during the Breast Parallel Session of the symposium. Abstracts were reviewed and accepted by a blind peer-review program committee.  

Duke Receives $20 million in Federal Research Grants

Separate awards will advance genomic medicine and breast cancer research
 

In separate awards from the National Institutes of Health, Duke University School of Medicine researchers will advance genomic medicine initiatives and develop a model for how breast cancer tumors begin and grow.

The genome studies include two grants from the National Human Genome Research Institute, which is part of NIH, that will total about $9 million over five years. 

Dynamic Equilibrium: Finding Balance for the Surgeon–Scientist

With a buzzing phone and dinging inbox repeatedly begging for her attention, Dr. Georgia Beasley momentarily tunes out the chaos to discuss the journey that led to her current position at Duke. Here, she splits her time between treating melanoma patients in the clinic and researching novel treatments for the disease in the laboratory.